Natalie George
Physician Assistant · Birmingham, ALNPI 1114298510
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $428,271 of the $539,947 with a category attached, or 79.3%. 30 manufacturers reported payments, led by AbbVie at 36.4% of the total. Among physician assistant clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,692 payments — averaging $319.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$197K
- Lilly USA, LLC$64K
- Johnson & Johnson$62K
- Dermavant Sciences, Inc.$48K
- Organon$29K
- Regeneron Healthcare Solutions, Inc.$28K
- plus $113K from 24 others
What the payments were for
- Consulting fees$33,8696%
- Speaking & faculty fees$428,27179%
- Travel & lodging$46,3319%
- Food & beverage$30,9046%
- Education$5720%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 480 | $196,513 |
| Lilly USA, LLC | 155 | $63,579 |
| Johnson & Johnson | 138 | $61,676 |
| Dermavant Sciences, Inc. | 142 | $48,045 |
| Organon | 73 | $29,285 |
| Regeneron Healthcare Solutions, Inc. | 96 | $27,876 |
| Incyte Corporation | 151 | $26,786 |
| Sanofi | 51 | $25,266 |
| E.r. Squibb & Sons, L.L.C. | 78 | $24,404 |
| Janssen Scientific Affairs, LLC | 20 | $14,282 |
| Novartis | 61 | $6,954 |
| UCB, Inc. | 31 | $5,773 |
| LEO Pharma Inc. | 28 | $4,572 |
| EPI Health, LLC | 5 | $1,685 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 56 | $962 |
| Pfizer | 39 | $601 |
| Sun Pharmaceutical Industries Inc. | 11 | $332 |
| Arcutis Biotherapeutics, Inc. | 24 | $330 |
| VYNE Pharmaceuticals Inc. | 6 | $299 |
| Galderma Laboratories, L.p. | 26 | $202 |
| Amgen | 6 | $109 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Organogenesis Inc. | 1 | $88 |
| Journey Medical Corporation | 3 | $63 |
| Botanix SB Inc | 3 | $57 |
| Mayne Pharma Commercial LLC | 3 | $34 |
| Bristol Myers Squibb | 1 | $26 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Tactile Systems Technology Inc | 1 | $15 |
| Fresenius Kabi USA, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$539,947 in reported general payments places this provider in the 95th percentile of 846 physician assistant providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Taltz AutoinjectorIxekizumab | 76 | $511,726 |
| Humira(Cf) PenAdalimumab | 32 | $416,682 |
| Dupixent PenDupilumab | 71 | $263,955 |
| Skyrizi PenRisankizumab-Rzaa | 13 | $261,671 |
| RinvoqUpadacitinib | 40 | $250,414 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 30 | $218,549 |
| Cimzia (2 Pack)Certolizumab Pegol | 12 | $131,441 |
| Fluorouracil | 216 | $20,444 |
| Clobetasol Propionate | 250 | $11,790 |
| Tacrolimus | 41 | $9,114 |
| Ivermectin | 11 | $4,167 |
| Ketoconazole | 125 | $3,130 |
| Fluocinolone AcetonideFluocinolone/Shower Cap | 55 | $3,032 |
| Triamcinolone Acetonide | 143 | $2,516 |
| Doxycycline Hyclate | 95 | $2,294 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq | $196,513 | $250,41440 claims |
| UCB, Inc.Cimzia (2 Pack) | $5,773 | $131,44112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 846 physician assistant providers in Alabama.
Other physician assistant in Birmingham
- Valerie GoodwinBirmingham$21K
- Mary TemplinBirmingham$19K
- Marena WindleBirmingham$14K
- Carolyn SmallwoodBirmingham$9K
- Emily DillardBirmingham$9K
- Victoria CarterBirmingham$8K
- Amber JacksonBirmingham$7K
- Lauren MillerAnniston$487K
- Brianna BarryEnterprise$29K
- Ashley PeaceMobile$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.